Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss drug Zepbound through a new partnership with Eli Lilly.

According to Ro’s site, the lower-dose version of the Zepbound vials costs $399 a month and the higher-dose version costs $549 a month. Lilly’s deal appears to be an effort to get a toehold in ...

Direct-to-consumer health-care startup Ro said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly.

Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s. Vials of the weight loss therapy will be made available through the telehealth platform ...

Patients can now obtain a single-dose vial of Zepbound for $399 and a four-count package for $549 through the Ro app, at a fraction of the drug’s list price of $1,060 per fill before insurance ...